Venture Partner, Therapeutics
NLC Health VenturesCheck size: NLC publishes venture and fund participation routes but not one standard direct-investment check-size range.
Kathrin Ballesteros, PhD invests or supports investments through NLC Health Ventures's published strategy: Find, build and scale health innovations from universities, hospitals and corporates, investing alongside founders and external investors.
Validated inventions addressing unmet healthcare needs with strong clinical relevance, protectable technology and scalable commercial potential.
Innovations without a clear healthcare need, feasible development path or meaningful patient impact are less aligned.
Explain the invention, unmet need, evidence, IP, regulatory path, team needs and why NLC's venture-building model is useful.
No writing has been linked yet. Kit can search for posts, interviews, and fund essays worth reading before outreach.
No podcast appearances are linked yet. Ask Kit to check for interviews that reveal how this investor thinks.
Quote coverage is incomplete. Kit can look for direct comments on markets, founders, and investment criteria.
Kathrin Ballesteros, PhD is a current Venture Partner, Therapeutics at NLC Health Ventures, according to the firm's official roster. No additional background is inferred where the firm does not publish a biography.